To assess trends and factors driving aggressive surgery for patients >75 years diagnosed with prostate cancer (CaP), bladder cancer (BCa), and renal cell carcinoma (RCC).
We identified all patients >75 years diagnosed with CaP, BCa, and RCC from the SEER-Medicare registry during 1992-2009.